Verrica Pharmaceuticals Q1 2026 Earnings EPS Miss Amid PreRevenue Stage Stock Rises 271 Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Beats Expectations as Pipeline Progress Continues CIG Q1 2026 Earnings EPS Beat Fails to Ignite Stock as Revenue Details Remain Absent ThredUp Q1 2026 Earnings NarrowerthanExpected Loss Lifts Shares FPI Q1 2026 Earnings EPS Misses Estimates Amidst Agricultural Market Challenges Eaton Vance Municipal Income 2028 Term Trust ETX Holds Steady Near 19 as Market Digests Stable Yields Wingstock Surges Over 5 Testing Key Resistance Levels Oxford Lane Capital Notes OXLCL Edge Higher at 2433 as Income Investors Monitor Key Levels Clipper Realty Inc CLPR Tests Support as Selling Pressure Mounts Shattuck Labs Q1 2026 Earnings NarrowerThanExpected Loss Amid Pipeline Progress